MS-13 Convict Files to Join Suit Challenging Limits on Gender-Affirming Treatment in Federal Prisons

(DailyAnswer.org) – A convicted MS-13 murderer is trying to use the courts to force federal prisons—and taxpayers—to provide “gender-affirming” treatments and female-only accommodations.

Quick Take

Oscar Contreras Aguilar, an MS-13 gang member convicted in a 2016 murder of a 14-year-old in Virginia, is seeking to join the ACLU-led class action Kingdom v. Trump.
The lawsuit targets Trump’s Executive Order 14168 and related Bureau of Prisons policies limiting taxpayer-funded gender-transition services in federal custody.
A federal judge issued a preliminary injunction in 2025 that kept some hormone treatments and certain “social transition” items available, while not requiring surgery.
The Justice Department is pushing back, arguing parts of the case rely on “unsubstantiated” retaliation allegations and disputing contempt claims.

What the MS-13 inmate is asking the courts to order

Oscar Contreras Aguilar—who identifies in filings as “Fendi G. Skyy” and has also been described as using the MS-13 moniker “Atrevido”—is incarcerated in the federal system after conviction tied to the 2016 killing of a 14-year-old boy in Fairfax County, Virginia. Aguilar is now seeking class membership in Kingdom v. Trump, a case challenging limits on hormones and other accommodations for transgender federal inmates.

Aguilar’s court claims, as summarized in reporting and case descriptions, include complaints about being “misgendered,” being searched by male guards, and being denied items such as bras, makeup, and other “social transition” accommodations. The filing also alleges emotional distress and suicidal ideation tied to those denials. The immediate legal question is not whether the crimes were severe—they were—but whether federal policy can restrict what is framed as medical or quasi-medical care in prison.

How Trump’s prison policy collided with federal injunctions

President Trump’s Executive Order 14168, issued on Jan. 20, 2025, set a “biological sex” framework and moved to prohibit gender-affirming care in federal prisons, aiming to end what the administration argued was ideologically driven spending and policy. That shift triggered litigation from the ACLU and the Transgender Law Center on behalf of a reported class of roughly 2,000 transgender inmates diagnosed with gender dysphoria.

In June 2025, a federal judge granted a preliminary injunction that blocked the suspension of hormone therapy and allowed some “social” items, while not ordering sex-reassignment surgery. That injunction left the Bureau of Prisons and the DOJ navigating a narrow lane: they could defend the executive order and attempt to implement restrictions, but they could not simply shut off all previously available hormone treatment where the court found legal grounds to keep it in place pending further rulings.

DOJ’s response and the fight over “contempt” claims

Aguilar filed on March 11, 2026, to join the Kingdom class action, alleging the Bureau of Prisons was denying “social accommodations” and implying noncompliance with the injunction. According to the reported timeline, the DOJ responded days later—March 16—by seeking reconsideration and disputing the underlying premise of certain allegations, including claims characterized by the government as “unsubstantiated.” The government also cited examples meant to rebut retaliation narratives in the broader dispute.

This procedural posture matters because it determines who sets the rules inside federal prisons: elected executive leadership implementing policy, or courts refining—and sometimes freezing—policy during litigation. Conservatives who prioritize limited government can recognize the tension here. The Constitution requires due process and prohibits cruel and unusual punishment, but it does not require judges to manage day-to-day prison life as a default. The more prison policy gets litigated down to bras, cosmetics, and search protocols, the more federal governance shifts from elections to injunction battles.

Why this case hits a nerve with law-and-order voters

The facts at the center of this filing collide with public expectations about justice, victims, and basic priorities. Reporting describes Aguilar as an MS-13 gang member convicted in a brutal murder involving a knife and machete, with the victim’s body buried. For many Americans—especially voters who backed Trump for border enforcement and law-and-order—there is a moral clarity to putting criminals behind bars and focusing resources on safety, not on identity-driven perks.

At the same time, the litigation shows how durable “woke” frameworks can be inside institutions even after elections shift. Trump’s order sought to reassert “biological truth” standards, yet the system remains constrained by prior medical policies, Eighth Amendment arguments, and judicial rulings that can preserve access to certain treatments for years. With limited information in the public summaries about exact costs and the current status of Aguilar’s medical regimen at USP Coleman II, the debate remains more about governance and precedent than a single line item.

Imprisoned MS-13 gang member sues Trump administration to get sex-change treatment https://t.co/K2xeRyC0Ji

— The Washington Times (@WashTimes) March 24, 2026

For voters already exhausted by inflation, high costs, and the sense that government focuses on the wrong problems, the political risk is straightforward: when the public sees court fights over gender accommodations for a violent gang criminal, confidence in institutions drops. Whether courts ultimately narrow or expand the injunction, the broader takeaway is that administrative reforms do not end the dispute—they often just move it to judges, where outcomes can hinge on procedural arguments and evolving interpretations of what prison “care” must include.